Tag:

Apotex

Latest Headlines

Latest Headlines

Canadian drugmaker's Indian plant joins FDA import ban parade

The FDA has banned a handful of plants from some of India's biggest drugmakers in the last year, actions that have led to grumbling that the regulator is picking on Indian-owned operations. But now a plant in India owned by a Canadian firm has gotten the same treatment, an import alert that blocks products from being shipped to the U.S.

Apotex plant in India tagged with import ban

The FDA has again issued an import alert against a plant owned by Canadian generic drugmaker Apotex, this one in India. The last time the agency took that kind of action, Apotex took the matter to international authorities in a North American Free Trade Agreement complaint.

Apotex ordered to pay AstraZeneca half its generic Prilosec profits

An award of $76 million may not sound like much in the big-dollar world of pharma, but for a branded drug company, it always feels good to win one against a generic drugmaker that has jumped the gun with a generic. That is how much a court says AstraZeneca should be paid by Apotex.

Apotex sued over problems on contraceptive packaging line

Forty-five women are seeking $800 million (U.S. $778.8 million) in a class-action lawsuit filed Friday, claiming a packaging foul-up by Apotex led them to take placebos instead of the active birth control pills.

More recalls as Hospira struggles to right manufacturing

It has been a particularly bad few days for Hospira, with both the company and the FDA alerting healthcare providers of problems with multiple lots of its drugs. That was in addition to an alert for one of its medical products.

Drugmakers 'illegally' withhold samples from would-be copycats

Risk-management plans may be a burden for new drug launches, but they're proving to be a weapon against generic competition, too. As the  New York Times  reports, generics makers can't buy the supplies they need to knock off a product, thanks to REMS restrictions. So, they have to resort to asking branded drugmakers for supplies--and some of those companies aren't cooperating.

FDA on Apotex's case for plant problems

The generic drug manufacturer, which for nearly two years had its products banned from the U.S., has received a warning letter for two of its in Canada plants, one in Ontario and one in Toronto that has received a warning letter before.

Merck loses a patent ruling on blockbuster Nasonex

Even as the clock is ticking down on the patent for its super blockbuster Singulair, Merck ($MRK) got smacked Friday with a negative decision in its battle with genericmaker Apotex over Merck's blockbuster Nasonex spray.

Generic floodgates open for Plavix in U.S.

Plavix is a blood thinner from Bristol-Myers Squibb ($BMY). Generic Plavix is a Bristol-Myers profits thinner that is going to be produced by just about everybody and their brother.

UPDATED: Supreme Court upholds Unigene's nasal delivery patent

Unigene Laboratories can hold on to its patent for Fortical, after the Supreme Court denied Apotex's petition this week.